Literature DB >> 16406678

Expression of compstatin in Escherichia coli: incorporation of unnatural amino acids enhances its activity.

Madan Katragadda1, John D Lambris.   

Abstract

Compstatin, a 13-residue cyclic peptide, is a complement inhibitor that shows therapeutic potential. Several previous approaches have improved the activity of this peptide several-fold. In the present study, we have expressed and purified compstatin from Escherichia coli in an effort to increase its potency and to generate it in high yield in a more economical fashion. An intein-based expression system was used to express compstatin in fusion with chitin-binding domain and Ssp DnaB intein, which were later cleaved from the expressed molecule at room temperature and pH 7.0 to yield pure compstatin in one step. The expressed compstatin showed activity similar to the synthetic compstatin in an ELISA-based assay. The same expression system and purification strategy were used to incorporate three tryptophan analogs, 6-fluoro-tryptophan, 5-hydroxy-tryptophan, and 7-aza-tryptophan, into compstatin. Interestingly, incorporation of 6-fluoro-tryptophan increased the activity three-fold relative to wild-type compstatin; in contrast, incorporation of 5-hydroxy- or 7-aza-tryptophan rendered compstatin less active than the wild-type form.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16406678     DOI: 10.1016/j.pep.2005.11.016

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  4 in total

Review 1.  Compstatin: a complement inhibitor on its way to clinical application.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

2.  Effect of variation of the strength of the aromatic interactions of tryptophan on the cooperative structural refolding behavior of a peptide from HIV 1.

Authors:  Simon Schweizer; Jennifer Reed
Journal:  Biophys J       Date:  2008-07-03       Impact factor: 4.033

3.  Development of a new pharmacophore model that discriminates active compstatin analogs.

Authors:  Ting-Lan Chiu; Chandrika Mulakala; John D Lambris; Yiannis N Kaznessis
Journal:  Chem Biol Drug Des       Date:  2008-10       Impact factor: 2.817

4.  New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristics.

Authors:  Ronald D Gorham; David L Forest; George A Khoury; James Smadbeck; Consuelo N Beecher; Evangeline D Healy; Phanourios Tamamis; Georgios Archontis; Cynthia K Larive; Christodoulos A Floudas; Monte J Radeke; Lincoln V Johnson; Dimitrios Morikis
Journal:  J Med Chem       Date:  2014-12-29       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.